feature image

Institutional Biosafety Committee

The Institutional Biosafety Committee is responsible for monitoring and ensuring compliance as well as review and approval of all research projects that involve recombinant or synthetic nucleic acid molecules, including human gene transfer (clinical trials) in accordance with the NIH Guidelines.

News

 IMPORTANT INFORMATION  

The IBC uses the MyIBC on-line application processing system for review for all New or Full Renewal protocols

Essential Step:

  Research Guidance Tool>>

page updated 05 July 2016